{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:26:46Z","timestamp":1787318806001,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejpb.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:48:44Z","timestamp":1602204524000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis"],"prefix":"10.1016","volume":"157","author":[{"given":"Shugo","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemasa","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayane","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyasu","family":"Sakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.10.001_b0005","first-page":"4060","article-title":"Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer","volume":"7","author":"Fedarko","year":"2001","journal-title":"Clin. Can. Res."},{"key":"10.1016\/j.ejpb.2020.10.001_b0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Can. Cell"},{"key":"10.1016\/j.ejpb.2020.10.001_b0015","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0020","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1200\/JCO.2005.03.0841","article-title":"Pathogenesis and treatment of prostate cancer bone metastasis: targeting the lethal phenotype","volume":"23","author":"Loberg","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2010.32.5209","article-title":"American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer","volume":"29","author":"van Poznak","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0030","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2165\/00003088-200342150-00002","article-title":"Bone-specific drug delivery systems","volume":"42","author":"Hirabayashi","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2020.10.001_b0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10611869509015956","article-title":"Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I: synthesis and in vivo characterization of osteotropic carboxyfluorescein","volume":"3","author":"Fujisaki","year":"1995","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2020.10.001_b0040","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/j.biomaterials.2013.01.052","article-title":"Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases","volume":"34","author":"Miller","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.10.001_b0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/1061186X.2018.1434659","article-title":"Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis","volume":"26","author":"Yamashita","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2020.10.001_b0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/mp0600539","article-title":"Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers","volume":"3","author":"Wang","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.10.001_b0055","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.actbio.2014.07.015","article-title":"Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation","volume":"10","author":"Fu","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2020.10.001_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2017.10.053","article-title":"Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis","volume":"154","author":"Yamashita","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.10.001_b0065","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.2147\/IJN.S211981","article-title":"Dual targeting curcumin loaded alendronate-hyaluronan-octadecanoic acid micelles for improving osteosarcoma therapy","volume":"14","author":"Xi","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2020.10.001_b0070","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1073\/pnas.1401337111","article-title":"Engineered nanomedicine for myeloma and bone microenvironment targeting","volume":"111","author":"Swami","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejpb.2020.10.001_b0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nature02079","article-title":"Bone recognition mechanism of porcine osteocalcin from crystal structure","volume":"425","author":"Hoang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2020.10.001_b0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjc.6603285","article-title":"Association of 12 serum biochemical markers of angiogenesis, tumor invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation","volume":"95","author":"Voorzanger-Rousselot","year":"2006","journal-title":"Br. J. Can."},{"key":"10.1016\/j.ejpb.2020.10.001_b0085","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/acs.chemrev.5b00367","article-title":"A systematic framework and nanoperiodic concept for unifying nanoscience: hard\/soft nanoelements, superatoms, meta-atoms, new emerging properties, periodic property patterns, and predictive mendeleev-like nanoperiodic tables","volume":"116","author":"Tomalia","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2020.10.001_b0090","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.molpharmaceut.6b00557","article-title":"Development of PEGylated cysteine-modified lysine dendrimers with multiple reduced thiols to prevent hepatic ischemia\/reperfusion injury","volume":"13","author":"Katsumi","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.10.001_b0095","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1021\/ma0008544","article-title":"Stabilization of Pluronic P-105 micelles with an interpenetrating network of N,N-diethylacrylamide","volume":"33","author":"Pruitt","year":"2000","journal-title":"Macromolecules"},{"key":"10.1016\/j.ejpb.2020.10.001_b0100","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1248\/bpb.b12-0020","article-title":"Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer","volume":"35","author":"Araki","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2020.10.001_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.07.018","article-title":"Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases","volume":"262","author":"Yamashita","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.001_b0110","doi-asserted-by":"crossref","unstructured":"K. Hyoudou, M. Nishikawa, Y. Umeyama, Y. Kobayashi, F. Yamashita, M. Hashida M, Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells, Clin. Cancer Res. 10 (2004) 7685\u20137691, https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1020.","DOI":"10.1158\/1078-0432.CCR-04-1020"},{"key":"10.1016\/j.ejpb.2020.10.001_b0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0020-708X(82)90144-2","article-title":"The preparation and labeling of DTPA-coupled albumin","volume":"33","author":"Hnatowich","year":"1982","journal-title":"Int. J. Appl. Radiat. Isot."},{"key":"10.1016\/j.ejpb.2020.10.001_b0120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (MULTI) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.ejpb.2020.10.001_b0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1016489002393","article-title":"Disposition and tumor localization of mitomycin C-dextran conjugates in mice","volume":"4","author":"Takakura","year":"1987","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.10.001_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-3659(94)00025-5","article-title":"Pharmacokinetics in design of polymeric drug delivery systems","volume":"31","author":"Hashida","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.001_b0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/1040-8428(94)00131-C","article-title":"Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs","volume":"18","author":"Takakura","year":"1995","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0140","first-page":"1149","article-title":"Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In","volume":"47","author":"Brown","year":"1987","journal-title":"Can. Res."},{"key":"10.1016\/j.ejpb.2020.10.001_b0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/la00028a012","article-title":"Micelle based on AB block copolymers of poly(ethylene oxide) and poly(\u03b2-benzyl L-aspartate)","volume":"9","author":"Kwon","year":"1993","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2020.10.001_b0150","doi-asserted-by":"crossref","unstructured":"C. Liang, B. Guo, H. Wu, N. Shao, D. Li, J. Liu, L. Dang, C. Wang, H. Li, S. Li, W.K. Lau, Y. Cao, Z. Yang, C. Lu, X. He, D.W.T. Au, X. Pan, B. Zhang, C. Lu, H. Zhang, K. Yue, A. Qian, P. Shang, J. Xu, L. X., Z. Bian, W. Tan, Z. Liang, F. He, L. Zhang, Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy, Nat. Med. 21 (2015) 288\u2013294, https:\/\/doi.org\/10.1038\/nm.3791.","DOI":"10.1038\/nm.3791"},{"key":"10.1016\/j.ejpb.2020.10.001_b0155","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1021\/acsnano.5b07828","article-title":"Osteoblast-targeting-peptide modified nanoparticle for siRNA\/microRNA delivery","volume":"10","author":"Sun","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2020.10.001_b0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1679\/aohc.66.123","article-title":"Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects, and plants","volume":"66","author":"Kawamoto","year":"2003","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0165","first-page":"6876","article-title":"A murine model of experimental metastasis to bone and bone marrow","volume":"48","author":"Arguello","year":"1988","journal-title":"Can. Res."},{"key":"10.1016\/j.ejpb.2020.10.001_b0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3727\/096504001108747701","article-title":"Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice","volume":"12","author":"Miki","year":"2000","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ejpb.2020.10.001_b0175","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1200\/JCO.1995.13.11.2688","article-title":"Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study","volume":"13","author":"Gianni","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0180","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.139","article-title":"Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells","volume":"3","author":"Ajabnoor","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejpb.2020.10.001_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135966","article-title":"Molecular design of bisphosphonate-modified proteins for efficient bone targeting in vivo","volume":"10","author":"Katsumi","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2020.10.001_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.addr.2012.11.006","article-title":"Pharmacokinetic considerations for targeted drug delivery","volume":"65","author":"Yamashita","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.10.001_b0195","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2020.10.001_b0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5414\/CN109144","article-title":"Urinary calcium excretion and bone turnover in osteoporotic patients","volume":"88","author":"El-Husseini","year":"2017","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejpb.2020.10.001_b0205","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.10.001_b0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0014-5793(87)80506-9","article-title":"Large unilamellar liposomes with low uptake into the reticuloendothelial system","volume":"223","author":"Allen","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejpb.2020.10.001_b0215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0014-5793(92)80655-Z","article-title":"The polyoxyethylene\/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow","volume":"305","author":"Porter","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejpb.2020.10.001_b0220","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jconrel.2014.06.001","article-title":"Glycosylation-mediated targeting of carriers","volume":"190","author":"Kawakami","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.001_b0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/364343a0","article-title":"Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor","volume":"364","author":"Fraser","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2020.10.001_b0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1365-2567.1998.00393.x","article-title":"Nitric oxide-mediated cytotoxic effects of alveolar macrophages on transformed lung epithelial cells are independent of the \u03b22 integrin-mediated intercellular adhesion","volume":"93","author":"Hirano","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.ejpb.2020.10.001_b0235","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/aps.2016.48","article-title":"Nuclear-targeting TAT-PEG-Asp 8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer","volume":"37","author":"Pan","year":"2016","journal-title":"Acta Pharmcol. Sin."},{"key":"10.1016\/j.ejpb.2020.10.001_b0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0168-3659(01)00314-5","article-title":"Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core","volume":"74","author":"Nishiyama","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.001_b0245","doi-asserted-by":"crossref","first-page":"11582","DOI":"10.1074\/jbc.M610805200","article-title":"The reovirus sigma1 aspartic acid sandwich: a trimerization motif poised for conformational change","volume":"283","author":"Schelling","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.10.001_b0250","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/mp200083n","article-title":"Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model","volume":"8","author":"Miller","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.10.001_b0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2016.04.019","article-title":"Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer","volume":"232","author":"Adjei","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.001_b0260","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanism of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:39:44Z","timestamp":1760546384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120303015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":52,"alternative-id":["S0939641120303015"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}